$SSKN
STRATA Skin Sciences, Inc.

2021 Q3 Form 10-Q Financial Statement

#000114036121037603 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $7.711M $5.613M
YoY Change 37.38% -24.96%
Cost Of Revenue $2.335M $2.383M
YoY Change -2.01% -16.53%
Gross Profit $5.376M $3.230M
YoY Change 66.44% -30.16%
Gross Profit Margin 69.72% 57.54%
Selling, General & Admin $5.470M $3.980M
YoY Change 37.44% -22.04%
% of Gross Profit 101.75% 123.22%
Research & Development $371.0K $411.0K
YoY Change -9.73% 65.06%
% of Gross Profit 6.9% 12.72%
Depreciation & Amortization $575.0K $454.0K
YoY Change 26.65% -28.73%
% of Gross Profit 10.7% 14.06%
Operating Expenses $5.841M $4.391M
YoY Change 33.02% -17.99%
Operating Profit -$465.0K -$1.161M
YoY Change -59.95% 59.26%
Interest Expense -$52.00K -$20.00K
YoY Change 160.0% -113.07%
% of Operating Profit
Other Income/Expense, Net -$52.00K -$21.00K
YoY Change 147.62% -86.27%
Pretax Income -$517.0K -$1.182M
YoY Change -56.26% 34.01%
Income Tax $4.000K $72.00K
% Of Pretax Income
Net Earnings -$521.0K -$1.254M
YoY Change -58.45% 45.81%
Net Earnings / Revenue -6.76% -22.34%
Basic Earnings Per Share -$0.02 -$0.04
Diluted Earnings Per Share -$15.26K -$0.04
COMMON SHARES
Basic Shares Outstanding 34.02M 33.75M
Diluted Shares Outstanding 34.15M 33.75M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.05M $11.06M
YoY Change 17.97% -31.85%
Cash & Equivalents $13.05M $11.06M
Short-Term Investments
Other Short-Term Assets $623.0K $7.860M
YoY Change -92.07% 1383.02%
Inventory $3.225M $3.502M
Prepaid Expenses
Receivables $3.151M $2.510M
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.05M $24.94M
YoY Change -19.61% 3.97%
LONG-TERM ASSETS
Property, Plant & Equipment $6.403M $5.258M
YoY Change 21.78% 15.11%
Goodwill $8.803M
YoY Change 0.0%
Intangibles $6.697M
YoY Change -20.34%
Long-Term Investments
YoY Change
Other Assets $233.0K $298.0K
YoY Change -21.81% -17.91%
Total Long-Term Assets $26.71M $22.13M
YoY Change 20.72% -5.97%
TOTAL ASSETS
Total Short-Term Assets $20.05M $24.94M
Total Long-Term Assets $26.71M $22.13M
Total Assets $46.76M $47.06M
YoY Change -0.65% -0.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.480M $3.488M
YoY Change -28.9% 74.66%
Accrued Expenses $5.548M $4.558M
YoY Change 21.72% -7.68%
Deferred Revenue $1.864M
YoY Change -24.93%
Short-Term Debt $0.00 $7.280M
YoY Change -100.0%
Long-Term Debt Due $0.00 $1.134M
YoY Change -100.0% -55.07%
Total Short-Term Liabilities $12.15M $18.68M
YoY Change -34.94% 53.25%
LONG-TERM LIABILITIES
Long-Term Debt $7.282M $1.394M
YoY Change 422.38% -72.01%
Other Long-Term Liabilities $873.0K $52.00K
YoY Change 1578.85% -84.1%
Total Long-Term Liabilities $8.155M $1.446M
YoY Change 463.97% -72.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.15M $18.68M
Total Long-Term Liabilities $8.155M $1.446M
Total Liabilities $20.58M $21.14M
YoY Change -2.66% 13.27%
SHAREHOLDERS EQUITY
Retained Earnings -$218.5M
YoY Change 2.09%
Common Stock $34.00K
YoY Change 3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.18M $25.93M
YoY Change
Total Liabilities & Shareholders Equity $46.76M $47.06M
YoY Change -0.65% -0.95%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$521.0K -$1.254M
YoY Change -58.45% 45.81%
Depreciation, Depletion And Amortization $575.0K $454.0K
YoY Change 26.65% -28.73%
Cash From Operating Activities $452.0K $550.0K
YoY Change -17.82% -22.54%
INVESTING ACTIVITIES
Capital Expenditures -$1.057M -$720.0K
YoY Change 46.81% 67.44%
Acquisitions
YoY Change
Other Investing Activities -$3.473M
YoY Change
Cash From Investing Activities -$4.530M -$720.0K
YoY Change 529.17% 67.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 92.00K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 452.0K 550.0K
Cash From Investing Activities -4.530M -720.0K
Cash From Financing Activities 92.00K 0.000
Net Change In Cash -3.986M -170.0K
YoY Change 2244.71% -160.71%
FREE CASH FLOW
Cash From Operating Activities $452.0K $550.0K
Capital Expenditures -$1.057M -$720.0K
Free Cash Flow $1.509M $1.270M
YoY Change 18.82% 11.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-73000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
3473000
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20920000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16373000
us-gaap Cost Of Revenue
CostOfRevenue
7070000
us-gaap Cost Of Revenue
CostOfRevenue
6780000
us-gaap Gross Profit
GrossProfit
13850000
us-gaap Gross Profit
GrossProfit
9593000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1158000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
950000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9387000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6446000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7085000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5921000
us-gaap Operating Expenses
OperatingExpenses
17630000
us-gaap Operating Expenses
OperatingExpenses
13317000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3780000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3724000
sskn Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
2028000
sskn Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-93000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1935000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1845000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3762000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207000
us-gaap Net Income Loss
NetIncomeLoss
-1857000
us-gaap Net Income Loss
NetIncomeLoss
-3969000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
403000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
25927000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
320000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
585000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-521000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
26183000
sskn Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
2028000
sskn Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
7867000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7275000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-500000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
2528000
sskn Warrants Issued
WarrantsIssued
585000
sskn Warrants Issued
WarrantsIssued
0
sskn Assumed Deferred Revenue
AssumedDeferredRevenue
1841000
sskn Assumed Deferred Revenue
AssumedDeferredRevenue
0
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">Reclassifications</span></div> <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation. These reclassifications did not have a material impact on the Company’s equity, results of operations, or cash flows.</span><br/> </div>
CY2021Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3024000
CY2020Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2949000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
201000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
495000
CY2021Q3 us-gaap Inventory Net
InventoryNet
3225000
CY2020Q4 us-gaap Inventory Net
InventoryNet
3444000
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1549000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1148000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1549000
CY2021Q3 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
1148000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
401000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
73000
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
52000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
162000
CY2021Q3 sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
199000
sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
542000
CY2020Q3 sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
160000
sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
414000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7711000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20920000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5613000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16373000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25693000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23374000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19290000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17845000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6403000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5529000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
575000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1576000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
454000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1535000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-73000
CY2021Q3 sskn Disposal Group Including Discontinued Operation Property Plant And Equipment Gross
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentGross
204000
CY2021Q3 sskn Disposal Group Including Discontinued Operation Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21414000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10868000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10546000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16100000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9755000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6345000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
408000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1113000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
353000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1258000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
463000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1853000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1853000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1853000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1148000
CY2021Q3 sskn Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
3376000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10546000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
54000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
87000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1578000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
891000
CY2021Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3152000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3105000
CY2021Q3 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
764000
CY2020Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
607000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5548000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4690000
CY2021Q3 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
171000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
98000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
139000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
232000
CY2021Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
11000
CY2020Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
37000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
52000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
46000
CY2021Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
28000
CY2020Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
41000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
84000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
143000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
81000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
135000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
81000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
135000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
54000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
107000
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
54000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
107000
CY2021Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
27000
CY2020Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
28000
CY2021Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
27000
CY2020Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
28000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1000000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4000000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3000000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
8000000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
320000
us-gaap Share Based Compensation
ShareBasedCompensation
1563000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
403000
us-gaap Share Based Compensation
ShareBasedCompensation
1243000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.904
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Price
SharePrice
1.68
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
173000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
167000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y9M18D
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7711000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2335000
CY2021Q3 us-gaap Gross Profit
GrossProfit
5376000
CY2021Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.697
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
371000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3295000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2175000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5841000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-465000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-52000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-517000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20920000
us-gaap Cost Of Revenue
CostOfRevenue
7070000
us-gaap Gross Profit
GrossProfit
13850000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.662
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1158000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9387000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7085000
us-gaap Operating Expenses
OperatingExpenses
17630000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3780000
sskn Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
2028000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-93000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1845000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5613000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
2383000
CY2020Q3 us-gaap Gross Profit
GrossProfit
3230000
CY2020Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.575
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
411000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2051000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1929000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4391000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1161000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1182000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16373000
us-gaap Cost Of Revenue
CostOfRevenue
6780000
us-gaap Gross Profit
GrossProfit
9593000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.586
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
950000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6446000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5921000
us-gaap Operating Expenses
OperatingExpenses
13317000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3724000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3762000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
261000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
242000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
108000
us-gaap Operating Lease Cost
OperatingLeaseCost
331000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
112000
us-gaap Operating Lease Cost
OperatingLeaseCost
336000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
113000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
113000
us-gaap Operating Lease Payments
OperatingLeasePayments
344000
us-gaap Operating Lease Payments
OperatingLeasePayments
344000
sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
122000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
371000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
242000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
186000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
921000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
117000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
804000

Files In Submission

Name View Source Status
0001140361-21-037603-index-headers.html Edgar Link pending
0001140361-21-037603-index.html Edgar Link pending
0001140361-21-037603.txt Edgar Link pending
0001140361-21-037603-xbrl.zip Edgar Link pending
brhc10030718_10q.htm Edgar Link pending
brhc10030718_10q_htm.xml Edgar Link completed
brhc10030718_ex10-6.htm Edgar Link pending
brhc10030718_ex31-1.htm Edgar Link pending
brhc10030718_ex31-2.htm Edgar Link pending
brhc10030718_ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image00002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20210930.xsd Edgar Link pending
sskn-20210930_cal.xml Edgar Link unprocessable
sskn-20210930_def.xml Edgar Link unprocessable
sskn-20210930_lab.xml Edgar Link unprocessable
sskn-20210930_pre.xml Edgar Link unprocessable